Telesis Bio
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
10431 Wateridge Cir Ste 150, San Diego, ...Phone Number
(855) 474-4362Website
www.telesisbio.comRevenue
$19.6 MillionStock Symbol
TBIOIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About Telesis Bio
Telesis Bio empowers researchers with end-to-end solutions and tools they need to rapidly and securely design, code, and create synthetic DNA. Experience increases in productivity to your product development cycles. Creators of the BioXp system the worlds only synthetic biology workstation and the industry-standard Gibson Assembly® method, provide comprehensive end-to-end solutions across your synthetic biology workflows, Telesis Bio, Inc. is accelerating advances in the fields of personalized medicine, biologics drug discovery, vaccine development, genome editing, and cell and gene therapy.Explore more
Telesis Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Telesis Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Telesis Bio
Funding: Get notified immidiatlly once Telesis Bio has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check if Telesis Bio has recently received funding, and reach out quickly before it becomes old news!
Check out if Telesis Bio is spiking on competitors!
Product Launch: Get notified when Telesis Bio launches new products
Telesis Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Telesis Bio had a recent Job posting/layoffs
Earning: See what the market has to say on Telesis Bio recently announced quarterly report
Recommended Actions
Find VP level buyers at Telesis Bio
Find more new buyers
Compare Similar Companies to Telesis Bio
Compare insights from companies similar to Telesis Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Telesis Bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Telesis Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Telesis Bio.
Telesis Bio financials insights
Gather financial insights about Telesis Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Other Financing Round
$28M
Telesis Bio Tech Stack
A closer look at the technologies used by Telesis Bio
See more technologies
Most Recent Scoops
Event
Events, Engineering, Sales, Bioengineering, Laboratory Operations, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Operations
Event
Events, Engineering, Sales, Bioengineering, Laboratory Operations, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Operations
Person-Based
Event
Events, Engineering, Research & Development, Training, Machine Learning, Learning & Development, Search, Laboratory Operations, Medical Education & Training, Medical Research, Chemical Engineering, Artificial Intelligence, Clinical Operations, Healthcare Technology, HR Operations, Operations
Event
Events, Engineering, Research & Development, Training, Machine Learning, Learning & Development, Search, Laboratory Operations, Medical Education & Training, Medical Research, Chemical Engineering, Artificial Intelligence, Clinical Operations, Healthcare Technology, HR Operations, Operations
Telesis Bio News & Media
Telesis Bio secures $3 million in promissory notes - Investing.com
Telesis Bio secures $3 million in promissory notesTelesis Bio and Beckman Coulter Life Sciences Collaborate to Revolutionize DNA and mRNA Synthesis
Innovation Delivers High-Fidelity, Scalable, Non-Toxic On-Premises Biofoundry Capabilities Innovation Delivers High-Fidelity, Scalable, Non-Toxic On-Premises Biofoundry CapabilitiesTelesis Bio Plans to Delist its Securities from The Nasdaq Stock Market
SAN DIEGO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO) (“Telesis” or the “Company”), a leading provider of RNA and DNA solutions enabling researchers to accelerate therapeutic discovery through advanced, flexible, and rapid automated synthesis technology in their own lab, announced today that it has notified the Nasdaq Stock Market LLC (“Nasdaq”) of its decision to delist the Company’s shares of common stock, par value $0.001 per share (the “Common Stock”) andTelesis Bio Reports Second Quarter and First Half 2024 Financial Results
SAN DIEGO, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leading provider of RNA and DNA solutions enabling researchers to accelerate therapeutic discovery through advanced, flexible, and rapid automated synthesis technology in their own lab, today announced financial results for the second quarter and first half of 2024.
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Telesis Bio
Sign Up For FreeTo access detailed company insights
Telesis Bio empowers researchers with end-to-end solutions and tools they need to rapidly and securely design, code, and create synthetic DNA. Experience increases in productivity to your product development cycles. Creators of the BioXp system the worlds only synthetic biology workstation and the industry-standard Gibson Assembly® method, provide... Read More
